Molecular Devices to Buy Axon Instruments for $140M in Cash and Stock | GenomeWeb

NEW YORK, March 22 (GenomeWeb News) - Molecular Devices plans to acquire Axon Instruments for a total of $140 million in cash and stock, the company said yesterday.


Molecular Devices, based in Sunnyvale, Calif., hopes the acquisition will create synergies for product development and will help distribute Axon's products more effectively.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.